146 related articles for article (PubMed ID: 14613381)
1. Impact of multi-tiered pharmacy benefits on attitudes of plan members with chronic disease states.
Nair KV; Ganther JM; Valuck RJ; McCollum MM; Lewis SJ
J Manag Care Pharm; 2002; 8(6):477-91. PubMed ID: 14613381
[TBL] [Abstract][Full Text] [Related]
2. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans.
Ganther-Urmie JM; Nair KV; Valuck R; McCollum M; Lewis SJ; Turpin RS
Am J Manag Care; 2004 Mar; 10(3):201-8. PubMed ID: 15032257
[TBL] [Abstract][Full Text] [Related]
3. Member satisfaction related to self-reported cost share and difficulty in obtaining prescription drugs in a university pharmacy benefit plan.
Nau DP; Chi C; Mallya U; Kirking DM
J Manag Care Pharm; 2007 Mar; 13(2):135-41. PubMed ID: 17330974
[TBL] [Abstract][Full Text] [Related]
4. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
Cecil WT; Barnes J; Shea T; Coulter SL
J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
[TBL] [Abstract][Full Text] [Related]
5. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit.
Spence MM; Hui R; Chan J
J Manag Care Pharm; 2006 Jun; 12(5):377-82. PubMed ID: 16792444
[TBL] [Abstract][Full Text] [Related]
6. Predictors of satisfaction of health plan members with prescription drug benefits.
Motheral BR; Heinle SM
Am J Health Syst Pharm; 2004 May; 61(10):1007-14. PubMed ID: 15160776
[TBL] [Abstract][Full Text] [Related]
7. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
Klepser DG; Huether JR; Handke LJ; Williams CE
J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
[TBL] [Abstract][Full Text] [Related]
8. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
9. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.
Shrank WH; Stedman M; Ettner SL; DeLapp D; Dirstine J; Brookhart MA; Fischer MA; Avorn J; Asch SM
J Gen Intern Med; 2007 Sep; 22(9):1298-304. PubMed ID: 17647066
[TBL] [Abstract][Full Text] [Related]
10. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
Nemlekar P; Shepherd M; Lawson K; Rush S
J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of health plan member use of an online prescription drug price comparison tool.
Carroll NV; Mitchell MP; Cannon HE; York BW; Oscar RS
J Manag Care Pharm; 2010; 16(9):680-92. PubMed ID: 21067254
[TBL] [Abstract][Full Text] [Related]
12. The role of satisfaction and switching costs in Medicare Part D choices.
Han J; Ko DW; Urmie JM
Res Social Adm Pharm; 2014; 10(2):398-407. PubMed ID: 23988694
[TBL] [Abstract][Full Text] [Related]
13. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
[TBL] [Abstract][Full Text] [Related]
14. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
15. Do consumers' attitudes predict prescription purchasing behavior?
Nair KV
Manag Care Interface; 2003 Jun; 16(6):22-7, 55. PubMed ID: 12841073
[TBL] [Abstract][Full Text] [Related]
16. The effect of a three-tier formulary on antidepressant utilization and expenditures.
Hodgkin D; Parks Thomas C; Simoni-Wastila L; Ritter GA; Lee S
J Ment Health Policy Econ; 2008 Jun; 11(2):67-77. PubMed ID: 18509214
[TBL] [Abstract][Full Text] [Related]
17. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.
Fairman KA; Motheral BR; Henderson RR
Clin Ther; 2003 Dec; 25(12):3147-61; discussion 3144-6. PubMed ID: 14749153
[TBL] [Abstract][Full Text] [Related]
18. An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plans.
Robinson SW; Brantley K; Liow C; Teagarden JR
J Manag Care Spec Pharm; 2014 Oct; 20(10):997-1004. PubMed ID: 25278322
[TBL] [Abstract][Full Text] [Related]
19. Early experience with employee choice of consumer-directed health plans and satisfaction with enrollment.
Fowles JB; Kind EA; Braun BL; Bertko J
Health Serv Res; 2004 Aug; 39(4 Pt 2):1141-58. PubMed ID: 15230917
[TBL] [Abstract][Full Text] [Related]
20. Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic Disease.
Nair KV; Wolfe P; Valuck RJ; McCollum MM; Ganther JM; Lewis SJ
J Manag Care Spec Pharm; 2020 May; 26(5):575-585. PubMed ID: 32347176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
